Abstract

BackgroundTo evaluate inter-fractional variations in bladder and rectum during prostate stereotactic body radiation therapy (SBRT) and determine dosimetric and clinical consequences.MethodsEighty-five patients with 510 computed tomography (CT) images were analyzed. Median prescription dose was 40 Gy in 5 fractions. Patients were instructed to maintain a full bladder and empty rectum prior to simulation and each treatment. A single reviewer delineated organs at risk (OARs) on the simulation (Sim-CT) and Cone Beam CTs (CBCT) for analyses.ResultsBladder and rectum volume reductions were observed throughout the course of SBRT, with largest mean reductions of 86.9 mL (19.0%) for bladder and 6.4 mL (8.7%) for rectum noted at fraction #5 compared to Sim-CT (P < 0.01). Higher initial Sim-CT bladder volumes were predictive for greater reduction in absolute bladder volume during treatment (ρ = − 0.69; P < 0.01). Over the course of SBRT, there was a small but significant increase in bladder mean dose (+ 4.5 ± 12.8%; P < 0.01) but no significant change in the D2cc (+ 0.8 ± 4.0%; P = 0.28). The mean bladder trigone displacement was in the anterior direction (+ 4.02 ± 6.59 mm) with a corresponding decrease in mean trigone dose (− 3.6 ± 9.6%; P < 0.01) and D2cc (− 6.2 ± 15.6%; P < 0.01). There was a small but significant increase in mean rectal dose (+ 7.0 ± 12.9%, P < 0.01) but a decrease in rectal D2cc (− 2.2 ± 10.1%; P = 0.04). No significant correlations were found between relative bladder volume changes, bladder trigone displacements, or rectum volume changes with rates of genitourinary or rectal toxicities.ConclusionsDespite smaller than expected bladder and rectal volumes at the time of treatment compared to the planning scans, dosimetric impact was minimal and not predictive of detrimental clinical outcomes. These results cast doubt on the need for excessively strict bladder filling and rectal emptying protocols in the context of image guided prostate SBRT and prospective studies are needed to determine its necessity.

Highlights

  • To evaluate inter-fractional variations in bladder and rectum during prostate stereotactic body radiation therapy (SBRT) and determine dosimetric and clinical consequences

  • In 10 patients, exact bladder volume could not be delineated due to limitations in field of view in Cone Beam CTs (CBCT) compared to full pelvic simulation computed tomography (CT)

  • simulation computed tomography (Sim-CT) bladder volume was inversely correlated with ­V5-SimBladder (ρ = − 0.69; P < 0.01); larger bladder volume at simulation was predictive of larger bladder volume loss toward fraction #5 (Fig. 2a)

Read more

Summary

Introduction

To evaluate inter-fractional variations in bladder and rectum during prostate stereotactic body radiation therapy (SBRT) and determine dosimetric and clinical consequences. Stereotactic body radiation therapy (SBRT) is gaining momentum for its clinical application of the treatment of localized prostate cancer. Comparable rates of genitourinary and bowel toxicities to IMRT have been reported in preliminary trials and multi-institutional experiences [1, 4,5,6, 13]. A Phase III non-inferiority clinical trial comparing conventional prostate EBRT to a seven-fraction prostate SBRT regimen (4270 cGy) revealed a comparable acute end-oftreatment urinary and bowel toxicity outcomes, as well as at 5-year follow-up [7]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call